Under construction – not a live service
Sign in
Taking people in United StatesPhase 2

Tests soluble fiber inulin for asthma in children

Tests inulin fiber or placebo in children aged 6 to 17 with asthma.

Plain-language title generated from the registry record
Registry title: A Clinical Trial of Soluble Fiber for Asthma

Key facts

Where
Phoenix, United StatesSee the site
Phase
Phase 2

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 6 and 17 years old?

Source: NCT06372249, who can take part

Where in United States

  • Phoenix Children'sPhoenix, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Phoenix Children's Hospital
Trial code
NCT06372249
Record updated
4 March 2026
Original description
Randomized controlled trial of soluble fiber (Fruitafit Inulin). Participants will complete an ASA 24 dietary recall questionnaire to access their fiber intake. If eligible for the study, participants will be supplemented to their target fiber dosage with either soluble fiber (Fruitafit Inulin) or placebo. Collection of blood serum, fecal samples, and nasal wash will aid in analyzing the microbes present in one's gut and how fiber and diet may impact it. Thus, allowing researchers to better understand the pathways that may connect diet and asthma and if it is possible to improve asthma by altering one's diet.Read full original descriptionShow less

A Phase ll Randomized Controlled Trial of Soluble Fiber for Asthma

Randomized controlled trial of soluble fiber (Fruitafit Inulin). Participants will complete an ASA 24 dietary recall questionnaire to access their fiber intake. If eligible for the study, participants will be supplemented to their target fiber dosage with either soluble fiber (Fruitafit Inulin) or placebo. Collection of blood serum, fecal samples, and nasal wash will aid in analyzing the microbes present in one's gut and how fiber and diet may impact it. Thus, allowing researchers to better understand the pathways that may connect diet and asthma and if it is possible to improve asthma by altering one's diet.

Inclusion: Between ages 6-17; Asthma diagnosis within the last 2 years; Fractional excretion of exhaled nitric oxide (FeNO) > 50 ppb OR a clinical history of environmental allergies as defined by a positive skin prick or positive specific immunoglobulin E (IgE) tests to aeroallergens; No emergency department visits in the past 1 month; Ability to consume a liquid drink of fiber or placebo; Ability to return for a 4-6 week follow-up visit; No special or unique diet.

Exclusion: Cystic fibrosis; Bronchiectasis; Change in asthma medicines other than short acting bronchodilators planned over the next 4-6 weeks; Baseline estimated daily fiber intake less than or equal to 16 grams as determined by the ASA 24; Sibling of a participant already enrolled in the study.

ClinicalTrials.gov NCT06372249